Skip to main content
UniHealth

Doctor search

David J Maron, MD

Cardiovascular Disease (Cardiology) · Stanford

NPI 1538251962

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
17
3 carriers
Office
1

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

17 plans · 3 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Maron’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

17 of 17 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
SCAN Balance (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
SCAN Classic (HMO)SCAN Health PlanListedOct 3, 2026
SCAN MyChoice (HMO)SCAN Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence G48267 · Current

Licensed to practise in California · since 1982 · expires 2027-11-30 · University of Southern California Keck School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

State licence records

1 licence

  • Tennessee 24919Medical Doctor · since 1993 · expires 2014-11-30Specialty on the licence: Cardiovascular Diseases
    Voluntarily RetiredNo board action on this licenceCheck it with the state

We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.

School, training and certification

4 placements

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Education

  • Univ of Southern CA · MDLOS ANGELES CA · 1981Medical school

Residency and fellowship

  • Fellowship CardiologySTANFORD CA USA · 1989–1991
  • Fellowship Robt Wood Johnson FellowSTANFORD CA USA · 1984–1986
  • Residency UCLALOS ANGELES CA USA · 1982–1984
  • Internship Internal Medicine UCLALOS ANGELES CA USA · 1981–1982

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$26,873

Medicare paid this office $26,873 for 279 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)52$8,446$156
New patient visit (60+ min)23$4,810$209
Return visit (30+ min)29$3,170$106
Long return visit (40+ min)14$1,787$128
Hospital discharge day management, 30 minutes or less23$1,618$70
See all 9 services
Every Original Medicare service billed
Long return visit (40+ min)52$8,446$156
New patient visit (60+ min)23$4,810$209
Return visit (30+ min)29$3,170$106
Long return visit (40+ min)14$1,787$128
Hospital discharge day management, 30 minutes or less23$1,618$70
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes18$1,569$44
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes19$1,305$69
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only101$849$7
Heart rhythm review and interpretation of continous external ekg over 8-15 days21$479$23

Who their Medicare patients are

279 Original Medicare patients in 2024. Average age 75 · Under 65 6% · 85 and older 14% · Women 46% · Also on Medicaid 21% · Health risk score 1.49. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.

Conditions among them: High blood pressure 75% · Coronary heart disease 59% · Atrial fibrillation 37% · Heart failure 34% · Chronic kidney disease 33% · Diabetes 32% · Depression 20% · Cancer 16% · COPD 14% · Stroke 13% · Dementia 8%.

The office billed $145,263, Medicare allowed $35,958 and paid $26,873; for 373 services of 17 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024279373751.49$145,263$26,873
2023167271761.27$138,782$22,342
2022471621732.16$136,759$22,128
2021249396741.65$134,469$23,239
2020389475742.26$89,452$13,422
2019306386741.81$40,616$13,579
2018253364741.69$50,779$16,342
2017618780721.94$81,885$18,392
2016375505731.73$77,015$17,851
2015125196721.71$51,096$13,671
201490151711.45$40,390$10,834
2013431485692.08$31,840$6,992

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 8 services

Original Medicare services billed in 2023
Long return visit (40+ min)48$6,278$116
New patient visit (60+ min)24$3,340$139
Return visit (30+ min)36$2,623$71
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes20$1,927$45
Hospital discharge day management, 30 minutes or less23$1,746$76
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes16$1,204$75
New patient visit (45+ min)11$1,126$102
Short return visit (20+ min)12$712$59

2022: 9 services

Original Medicare services billed in 2022
Long return visit (40+ min)37$4,540$108
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only315$2,753$8
New patient visit (45+ min)18$1,982$110
Return visit (30+ min)20$1,951$78
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes12$1,103$65
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes17$1,090$35
Hospital discharge day management, 30 minutes or less15$1,066$67
Short return visit (20+ min)13$546$42
Heart rhythm review and interpretation of continous external ekg over 8-15 days20$521$25

2021: 12 services

Original Medicare services billed in 2021
Long return visit (40+ min)39$5,695$124
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes18$2,287$127
New patient visit (60+ min)13$2,139$165
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes17$1,451$35
Return visit (30+ min)16$1,393$82
New patient visit (45+ min)13$1,390$107
Hospital discharge day management, 30 minutes or less17$1,223$68
Short return visit (20+ min)17$1,075$57
Hospital observation care on day of discharge13$968$69
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only106$883$8
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or12$540$30
Heart rhythm review and interpretation of continous external ekg over 8-15 days17$432$25

2020: 5 services

Original Medicare services billed in 2020
Return visit (30+ min)41$3,309$66
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only256$2,082$7
New patient visit (45+ min)19$1,716$90
Review and interpretation of external ekg recording for more than 48 hours up to 21 days33$753$23
Short return visit (20+ min)13$509$36

2019: 4 services

Original Medicare services billed in 2019
Return visit (30+ min)58$4,996$65
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only180$1,550$8
Long return visit (40+ min)11$1,266$97
Short return visit (20+ min)13$511$36

2018: 7 services

Original Medicare services billed in 2018
Return visit (30+ min)43$4,034$65
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes11$1,344$122
Hospital discharge day management, 30 minutes or less20$1,337$67
New patient visit (15+ min)22$952$43
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only112$925$7
Short return visit (20+ min)17$737$41
Ambulatory blood pressure monitoring, 1 day or longer, with review, interpretation and report12$222$17

2017: 8 services

Original Medicare services billed in 2017
Return visit (30+ min)51$4,758$62
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only466$3,864$7
New patient visit (45+ min)16$1,583$99
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes14$1,256$90
Hospital discharge day management, 30 minutes or less13$861$66
Review and interpretation of external ekg recording for more than 48 hours up to 21 days27$661$24
Short return visit (20+ min)11$456$41
Ambulatory blood pressure monitoring, 1 day or longer, with review, interpretation and report12$204$17

2016: 6 services

Original Medicare services billed in 2016
Return visit (30+ min)39$3,963$62
New patient visit (45+ min)24$2,478$103
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only209$1,799$7
Review and interpretation of external ekg recording for more than 48 hours up to 21 days45$1,055$23
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes16$1,046$35
Hospital discharge day management, 30 minutes or less12$724$60

2015: 4 services

Original Medicare services billed in 2015
Return visit (30+ min)25$3,008$67
New patient visit (45+ min)28$3,004$107
New patient visit (60+ min)14$2,096$150
Review and interpretation of external ekg recording for more than 48 hours up to 21 days46$1,106$24

2014: 6 services

Original Medicare services billed in 2014
New patient visit (60+ min)11$1,645$150
Return visit (30+ min)13$1,538$70
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes12$1,461$122
New patient visit (30+ min)12$810$68
Hospital discharge day management, 30 minutes or less11$786$65
Review and interpretation of external ekg recording for more than 48 hours up to 21 days30$726$24

2013: 2 services

Original Medicare services billed in 2013
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only352$2,232$6
Return visit (30+ min)29$1,679$51

Medicaid work

$276 in 2024

Medicaid paid $276 for 35 billed services this clinician did in 2024, up to 34 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only35$276
Medicaid work by year
202435134$276
20222961129$3,487
202190183$1,173
2020244177$3,074
2019112158$1,339
201872162$630
See the largest Medicaid services in earlier years

2022

Largest Medicaid services in 2022
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only296$3,487

2021

Largest Medicaid services in 2021
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only90$1,173

2020

Largest Medicaid services in 2020
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only244$3,074

2019

Largest Medicaid services in 2019
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only112$1,339

2018

Largest Medicaid services in 2018
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only72$630

Drugs they prescribed that Part D paid

$188,014

Pharmacies billed $188,014 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 965) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.

792 generic and fewer than 11 brand-name prescriptions · $188,014 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Repatha Sureclick86$79,692$927
Eliquis22$37,069$1,685
Jardiance13$19,517$1,501
Praluent13$7,279$560
Rosuvastatin147$3,190$22
See all 20 drugs
Every Part D drug this clinician prescribed
Repatha Sureclick86$79,692$927
Eliquis22$37,069$1,685
Jardiance13$19,517$1,501
Praluent13$7,279$560
Rosuvastatin147$3,190$22
Ezetimibe114$3,052$27
Colchicine16$1,523$95
Atorvastatin86$1,002$12
Carvedilol34$661$19
Metoprolol51$645$13
Amlodipine Besylate91$560$6
Clopidogrel22$315$14
Lisinopril33$244$7
Chlorthalidone12$212$18
Nitroglycerin20$207$10
Losartan24$206$9
Isosorbide Mononitrate Er17$168$10
Spironolactone27$143$5
Hydrochlorothiazide17$66$4
Losartan-Hydrochlorothiazide19$62$3

Year by year

Part D prescribing by year
20249651590% (0)None$188,014
20239331280% (0)19%$214,073
20228561210% (0)20%$187,634
20217591090% (0)20%$132,074
2020596980% (0)16%$82,770
2019512830% (0)15%$62,405
20185541210% (0)18%$103,613
20176521250% (0)23%$135,282
2016495930% (0)21%$55,309
2015310560% (0)16%$14,416
2014166390% (0)22%$8,292
201324237None31%$23,251

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 23 drugs

Part D drugs prescribed in 2023
Repatha Sureclick50$58,641$1,173
Eliquis20$36,676$1,834
Praluent33$29,625$898
Jardiance11$19,180$1,744
Vascepa20$8,684$434
Repatha13$7,997$615
Ezetimibe88$4,569$52
Rosuvastatin116$3,693$32
Colchicine17$3,221$189
Atorvastatin102$1,400$14
Carvedilol41$907$22
Metoprolol34$848$25
Chlorthalidone17$763$45
Amlodipine Besylate95$748$8
Clopidogrel23$511$22
Lisinopril46$489$11
Losartan26$240$9
Losartan-Hydrochlorothiazide11$218$20
Nitroglycerin11$185$17
Simvastatin11$178$16
Spironolactone14$174$12
Hydrochlorothiazide19$98$5
Isosorbide Mononitrate Er16$67$4

2022: 23 drugs

Part D drugs prescribed in 2022
Repatha Sureclick54$51,490$954
Eliquis22$29,561$1,344
Xarelto13$20,189$1,553
Jardiance12$15,259$1,272
Praluent15$11,578$772
Brilinta15$6,805$454
Repatha12$6,668$556
Vascepa13$6,452$496
Rosuvastatin98$5,312$54
Ezetimibe76$4,467$59
Colchicine20$3,839$192
Atorvastatin114$1,811$16
Metoprolol27$590$22
Amlodipine Besylate85$530$6
Chlorthalidone15$449$30
Clopidogrel24$412$17
Lisinopril47$350$7
Carvedilol22$335$15
Simvastatin14$311$22
Spironolactone19$264$14
Losartan26$227$9
Isosorbide Mononitrate Er16$165$10
Metoprolol13$19$1

2021: 19 drugs

Part D drugs prescribed in 2021
Repatha Sureclick30$26,644$888
Eliquis25$25,838$1,034
Vascepa27$14,870$551
Praluent26$13,027$501
Brilinta12$5,196$433
Ezetimibe75$4,259$57
Rosuvastatin86$3,141$37
Atorvastatin109$1,650$15
Chlorthalidone12$489$41
Clopidogrel24$433$18
Metoprolol18$380$21
Spironolactone30$275$9
Amlodipine Besylate53$259$5
Losartan17$244$14
Lisinopril38$206$5
Carvedilol22$148$7
Simvastatin11$73$7
Furosemide19$49$3
Metoprolol14$31$2

2020: 13 drugs

Part D drugs prescribed in 2020
Repatha Sureclick21$11,989$571
Xarelto12$11,505$959
Vascepa18$7,104$395
Ezetimibe75$6,764$90
Rosuvastatin87$3,310$38
Atorvastatin96$1,909$20
Chlorthalidone12$542$45
Metoprolol20$452$23
Nitroglycerin19$426$22
Losartan19$383$20
Clopidogrel21$277$13
Amlodipine Besylate35$217$6
Lisinopril25$194$8

2019: 15 drugs

Part D drugs prescribed in 2019
Eliquis19$16,482$867
Repatha Sureclick16$13,691$856
Olmesartan-Hydrochlorothiazide11$3,373$307
Ezetimibe52$3,108$60
Rosuvastatin60$2,261$38
Atorvastatin78$1,557$20
Nitroglycerin18$475$26
Chlorthalidone16$469$29
Metoprolol11$422$38
Clopidogrel24$396$16
Lisinopril24$320$13
Amlodipine Besylate34$248$7
Losartan24$225$9
Metoprolol15$144$10
Spironolactone11$127$12

2018: 13 drugs

Part D drugs prescribed in 2018
Praluent45$54,811$1,218
Eliquis11$8,575$780
Rosuvastatin62$3,699$60
Ezetimibe26$2,582$99
Atorvastatin102$2,266$22
Fluvastatin12$1,303$109
Metoprolol17$459$27
Isosorbide Mononitrate Er16$374$23
Losartan27$267$10
Clopidogrel19$260$14
Amlodipine Besylate42$214$5
Lisinopril21$174$8
Metoprolol11$68$6

2017: 16 drugs

Part D drugs prescribed in 2017
Praluent50$66,116$1,322
Repatha Sureclick24$26,340$1,098
Atorvastatin140$3,519$25
Rosuvastatin61$3,508$58
Metoprolol23$1,034$45
Chlorthalidone15$773$52
Amlodipine Besylate37$388$10
Losartan28$308$11
Clopidogrel16$297$19
Fenofibrate13$283$22
Hydrochlorothiazide19$204$11
Isosorbide Mononitrate Er12$184$15
Spironolactone13$182$14
Lisinopril20$167$8
Benazepril14$129$9
Metoprolol14$51$4

2016: 15 drugs

Part D drugs prescribed in 2016
Praluent14$16,157$1,154
Crestor15$5,535$369
Nexium11$3,840$349
Atorvastatin96$2,374$25
Chlorthalidone14$825$59
Metoprolol17$660$39
Amlodipine Besylate43$342$8
Spironolactone17$280$16
Hydrochlorothiazide27$280$10
Cartia Xt13$245$19
Lisinopril24$218$9
Potassium Chloride11$176$16
Losartan15$166$11
Benazepril13$68$5
Furosemide12$28$2

2015: 9 drugs

Part D drugs prescribed in 2015
Atorvastatin70$1,541$22
Metoprolol26$754$29
Irbesartan14$300$21
Carvedilol18$197$11
Spironolactone18$154$9
Hydrochlorothiazide15$154$10
Amlodipine Besylate18$118$7
Metoprolol12$101$8
Lisinopril15$99$7

2014: 4 drugs

Part D drugs prescribed in 2014
Atorvastatin33$844$26
Irbesartan12$448$37
Warfarin16$122$8
Amlodipine Besylate11$73$7

2013: 9 drugs

Part D drugs prescribed in 2013
Crestor25$5,360$214
Atorvastatin48$3,204$67
Diovan Hct12$1,482$124
Metoprolol16$1,242$78
Ramipril13$803$62
Diltiazem 24hr Er12$621$52
Warfarin21$242$12
Simvastatin13$198$15
Losartan11$113$10

Money from drug and device companies

$13,032 in 2025

Industry payments by year
202559$12,707$13,032
202411$793$793
202339$4,779$7,893

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

  • Ablative Solutions, Inc.

    Published ownership

    $3,578

    Held by this doctor · 2023 · Stock Warrant Granted. · amount invested $14,312

Published ownership or investment in a drug or device company. This is not proof that care is biased.

A payment is not proof that care is biased.

Payments by company
HeartflowFfrct$6,600
3 payments
  • Consulting for Ffrct · 2025-10-29 · $2,000
  • Consulting for Ffrct · 2025-10-16 · $1,600
  • Consulting for Ffrct · 2025-08-20 · $3,000
Bayer HealthcareNone$3,505
2 payments
  • Consulting · 2025-11-09 · $3,357
  • Meals · 2025-11-09 · $148
AbiomedNone$2,750
2 payments
  • Consulting · 2025-04-17 · $2,250
  • Consulting · 2025-02-05 · $500
Merck Sharp & DohmeNone$125
1 payment
  • Meals · 2025-11-08 · $125
Idorsia Pharmaceuticals USTryvio$52
1 payment
  • Education for Tryvio · 2025-08-06 · $52
See all 9 published payments
Every published payment
Bayer HealthcareConsulting · 2025-11-09None$3,357
Bayer HealthcareMeals · 2025-11-09None$148
Merck Sharp & DohmeMeals · 2025-11-08None$125
HeartflowConsulting · 2025-10-29Ffrct$2,000
HeartflowConsulting · 2025-10-16Ffrct$1,600
HeartflowConsulting · 2025-08-20Ffrct$3,000
Idorsia Pharmaceuticals USEducation · 2025-08-06Tryvio$52
AbiomedConsulting · 2025-04-17None$2,250
AbiomedConsulting · 2025-02-05None$500
See earlier years (2024, 2023)

2024: $793

Payments by company in 2024
Regeneron PharmaceuticalsNone$793
1 payment
  • Consulting · 2024-08-14 · $793

2023: $7,893

Payments by company in 2023
CleerlyNone$2,973
3 payments
  • Meals · 2023-11-13 · $124
  • Meals · 2023-11-11 · $2,498
  • Travel · 2023-11-09 · $350
Regeneron PharmaceuticalsNone$2,520
5 payments
  • Consulting · 2023-08-25 · $793
  • Consulting · 2023-08-25 · $793
  • Consulting · 2023-08-25 · $793
  • Meals · 2023-03-05 · $90
  • Meals · 2023-03-04 · $52
Scilex PharmaceuticalsGloperba$2,400
1 payment
  • Consulting for Gloperba · 2023-07-26 · $2,400

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Cleerly, Inc. · Transform · 2024Their institution$243,000
Cleerly, Inc. · Transform · 2025Their institution$162,000
Genentech, Inc. · Phase 1c Selnoflast Proof of Concept · 2024Their institution$98,542
AstraZeneca Pharmaceuticals LP · A Multinational Randomised Double Blind Placebo Controlled Trial To Evaluate the Effect of Ticagrelor 90 Mg Twice Daily on the Incidence of Cardiovascular Death Myocardial Infarction Or Stroke in Patients With Type 2 Diabetes · 2019Their institution$7,544

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1538251962
Licence
CA G48267, TN MD24919California G48267: Current · expires 2027-11-30Tennessee 24919: Voluntarily Retired
Trained
University of Southern California Keck School of Medicine, 1981
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Cardiology (207RC0000X); Internal medicine (207R00000X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2006-09-30
NPI last updated
2024-04-23
NPI record certified
2024-04-23

This is when the NPI record was last certified, not a medical board exam.